Surprise Castle
Breaking Life Sciences Vol I: THE GHOST GENOME The Hidden Chemical Language Inside Us - and Why Medicine Has Barely Begun to Read It

Breaking Life Sciences Vol I: THE GHOST GENOME The Hidden Chemical Language Inside Us - and Why Medicine Has Barely Begun to Read It - Hardcover

$25.99
$34.95
-26%
Quantity
01

Pay over time for orders over $35.00 with

Offers & Perks

Earn 25 points with this purchase

Added to your rewards balance after checkout.

100 points welcome bonus

Create an account and start with extra points.

Join now
Availability:In StockContributor:Ross O. YoungsSeries:Breaking Life SciencesPublish date:9/15/2026Pages:294
Languages:EnglishPublisher:Ross O. YoungsISBN-13:9798997360528UPC:9798997360528Book Category:Business & Economics, Science, ComputersBook Subcategory:Industries, Life Sciences, Data ScienceBook Topic:Pharmaceutical & Biotechnology, Biochemistry, Machine LearningSize:9.00 x 6.00 x 0.69 inchesWeight:0.563Product ID:SCNR5WWQ36

What if the Book of Life was only the table of contents?

In May 2000, the world's leading geneticists gathered at Cold Spring Harbor and bet real money on how many genes make a human. The winner was closest to 25,000. The actual count landed near 20,000. The "instruction manual" for human complexity was shockingly short. Something else had to be doing the work.

That something is the Ghost Genome: the dynamic chemical language produced when human genes, microbial communities, viruses, food, and environment interact in real time. Most of it remains invisible. Mass spectrometers detect oceans of unannotated peaks. Natural products still drive many of medicine's greatest successes. Yet drug discovery grows more expensive even as our tools grow more powerful-Eroom's Law running backward against Moore's Law.

Ross O. Youngs, inventor and architect of Industrial-Scale Microbiome Mining, traces this missing layer through ten true stories that change meaning the second time you meet them: the physician who drank a bacterial culture and rewrote ulcer disease; the exoplanet that shouldn't have existed; the soil microbe hidden in a household freezer that became rapamycin; twins whose microbes transferred metabolism to mice; phages standing guard in mucus; a lake too large for any Petri dish; the chip that sent microbes home; the day AI solved the right problem; and the soil organism whose chemistry reached hundreds of millions of people.

You will walk away with:

  • A clear distinction between genetic capacity and chemical execution-the difference between source code and a running system
  • Why counting genes, species, or virtual molecules cannot close the observability gap
  • Practical ways to treat evolutionary chemistry as a finite prior rather than an infinite search space
  • A research agenda that turns hidden activity into reproducible molecules, causal knowledge, and better starting points for medicine
  • A vision that extends from therapeutics to longevity, agriculture, ecosystem resilience, and closed-loop habitats

This is not another microbiome hype book. It is the first volume of the Breaking Life Sciences trilogy-a story-driven investigation into why medicine has barely begun to read the chemistry that actually coordinates life. For scientists, physicians, biotech founders, systems thinkers, and anyone who refuses to accept that the map is the territory.

The molecules are already there. They are simply waiting for instruments-and the permission-to look.

Languages:EnglishPublisher:Ross O. YoungsISBN-13:9798997360528UPC:9798997360528Book Category:Business & Economics, Science, ComputersBook Subcategory:Industries, Life Sciences, Data ScienceBook Topic:Pharmaceutical & Biotechnology, Biochemistry, Machine LearningSize:9.00 x 6.00 x 0.69 inchesWeight:0.563Product ID:SCNR5WWQ36
Youngs, Ross O.: - Ross O. Youngs is a biotechnology entrepreneur and the CEO of Biosortia, Inc., operating out of the Columbus, Ohio area. He leads the development of an Industrial-Scale Microbiome Mining platform, utilizing machine learning algorithms, in silico docking models, and advanced computational frameworks to accelerate small-molecule drug discovery. Also an executive associated with Univenture, Inc., he actively collaborates with leading academic researchers, multiple Ohio universities, and national laboratories-including Los Alamos National Laboratory-to scale next-generation metabolic therapeutics.
Publisher: Ross O. Youngs

Contributor(s)

Ross O. Youngs

Free shipping on orders over $75. Standard shipping takes 3-7 business days. Eligible items may be returned within 30 days of delivery. Conditions apply.